At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
In Brief
A Phase 2 clinical trial evaluating Buprenorphine and Outpatient Parenteral Antibiotic Therapy and Buprenorphine and standard of care antibiotic treatment for Drug Use and Opioid-use Disorder. Completed, enrolled 71 participants across 1 site.
Detailed Summary
This study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The investigators hypothesize that outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder will demonstrate a safe and effective way to manage patients. Results could improve the current protocols for the treatment of individuals with opioid use disorder and severe infections.
Study Details
Timeline
Interventions
Participants will be complete IV antibiotics with OPAT. All participants will receive buprenorphine treatment of OUD.
All participants will receive treatment of OUD and the infection per usual clinical care.